BRPI0916820A2 - processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas - Google Patents

processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas

Info

Publication number
BRPI0916820A2
BRPI0916820A2 BRPI0916820A BRPI0916820A BRPI0916820A2 BR PI0916820 A2 BRPI0916820 A2 BR PI0916820A2 BR PI0916820 A BRPI0916820 A BR PI0916820A BR PI0916820 A BRPI0916820 A BR PI0916820A BR PI0916820 A2 BRPI0916820 A2 BR PI0916820A2
Authority
BR
Brazil
Prior art keywords
microcapsules
patient
treating
composition
surface condition
Prior art date
Application number
BRPI0916820A
Other languages
English (en)
Inventor
Hanan Sertchook
Natalia Loboda
Ofer Toledano
Raed Abu-Reziq
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of BRPI0916820A2 publication Critical patent/BRPI0916820A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catching Or Destruction (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0916820A 2008-07-31 2009-08-02 processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas BRPI0916820A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8525508P 2008-07-31 2008-07-31
PCT/IL2009/000751 WO2010013250A2 (en) 2008-07-31 2009-08-02 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0916820A2 true BRPI0916820A2 (pt) 2015-11-03

Family

ID=41467117

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916820A BRPI0916820A2 (pt) 2008-07-31 2009-08-02 processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas

Country Status (13)

Country Link
US (2) US10688462B2 (pt)
EP (1) EP2307129A2 (pt)
JP (1) JP2011529392A (pt)
KR (1) KR20110084151A (pt)
CN (1) CN102112219A (pt)
AU (1) AU2009277962A1 (pt)
BR (1) BRPI0916820A2 (pt)
CA (2) CA2732368C (pt)
EA (1) EA201170271A1 (pt)
IL (1) IL210430A0 (pt)
MX (1) MX2011000682A (pt)
WO (1) WO2010013250A2 (pt)
ZA (1) ZA201101504B (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015815B1 (ru) 2005-08-02 2011-12-30 Сол-Джел Текнолоджиз Лтд. Покрытие из оксида металла для водонерастворимых ингредиентов
WO2007036939A2 (en) * 2005-09-27 2007-04-05 Sol-Gel Technologies Ltd. Methods for crop protection
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
JP2011529392A (ja) 2008-07-31 2011-12-08 ゾル−ゲル テクノロジー リミテッド 活性成分および金属酸化物シェルを含むマイクロカプセル、その製造方法およびその使用
EP2512234A4 (en) * 2009-12-15 2015-04-08 Sol Gel Technologies Ltd SILICAMIC CAPSULES WITH DELAYED RELEASE
BR112012012023A2 (pt) 2009-12-31 2016-05-17 Sol Gel Technologies Ltd processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US20110245136A1 (en) 2010-04-06 2011-10-06 Johan Smets Encapsulates
KR101457287B1 (ko) * 2010-04-20 2014-11-04 바스프 에스이 활성 성분을 포함하는 캡슐
IL275607B (en) 2010-06-07 2022-09-01 Syngenta Participations Ag Stabilized chemical composition
US20120039973A1 (en) * 2010-08-11 2012-02-16 Paul Grlica Composition and method of time releasing essential oils for animal repellency and pesticide use
ES2902498T3 (es) 2011-06-29 2022-03-28 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta
BR112014000141A2 (pt) 2011-07-06 2017-06-13 Harvard College emulsões múltiplas e técnicas para a formação de emulsões múltiplas
EP2788114B1 (en) * 2011-12-07 2021-03-24 Givaudan SA Process of making microcapsules
DE102012202069A1 (de) * 2012-02-10 2013-08-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Mikroverkapselter Schwefel mit einer Hülle auf Basis silicatischer Verbindungen
CN102640754B (zh) * 2012-04-01 2013-07-31 广东中迅农科股份有限公司 氰霜唑微胶囊悬浮剂及其制备方法
IN2014DN08496A (pt) 2012-04-12 2015-05-08 Idcaps
US9687465B2 (en) * 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP2925296B1 (en) * 2012-11-27 2021-01-06 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
CN105120660B (zh) * 2013-03-15 2018-03-27 奥麒化工股份有限公司 活性成分的包封和制造方法
EP2862447A1 (en) * 2013-10-16 2015-04-22 Idcaps Multilayer microcapsules containing an oxidizable active, and a process for preparing the same
CN104624125B (zh) * 2013-11-11 2018-03-02 中国人民银行印制科学技术研究所 一种光致变色双壳微胶囊及其制备方法和应用
WO2015092602A1 (en) * 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Topical pharmaceutical composition of a retinoid
JP2017518243A (ja) * 2014-03-11 2017-07-06 レ イノベーションズ マタレアム インコーポレイテッド シリカ−炭素同素体複合材料の調製および使用プロセス
US20150328240A1 (en) * 2014-05-19 2015-11-19 Carl Hilliard Product and delivery system for application of antimicrobial treatment designed to inhibit pathegens from entering or leaving a respitory system and to remove pathogens from wounds, ears or other body cavities, and methods of use
WO2016061095A1 (en) * 2014-10-14 2016-04-21 President And Fellows Of Harvard College Microcapsules and uses thereof
ES2885868T3 (es) 2015-04-17 2021-12-15 Univ Queensland Composición, materiales particulados y métodos para fabricar materiales particulados
CN104825421B (zh) * 2015-05-05 2017-11-17 陕西科技大学 用于疏水性小分子温控释放的有机‑无机双壳层微胶囊及其制备方法
JP7016534B2 (ja) * 2015-10-20 2022-02-07 マサチューセッツ インスティテュート オブ テクノロジー 流体の表面保持のためのシステムおよび方法
WO2017195913A1 (ko) * 2016-05-11 2017-11-16 (주)케이피티 이산화티탄을 함유하는 고형 에멀젼 비드 및 이를 사용하는 즉시 미백용 화장조성물
CA3069359C (en) * 2017-07-12 2023-01-10 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
JP6824842B2 (ja) * 2017-07-13 2021-02-03 クミアイ化学工業株式会社 農薬活性成分の溶出が制御された農薬組成物
EP3764789A2 (en) 2018-03-12 2021-01-20 Massachusetts Institute of Technology Articles and systems involving reaction products on surfaces and associated methods
US12290068B2 (en) * 2018-05-27 2025-05-06 The State Of Israel, Ministry Of Agriculture & Rural Development Agricultural Research Organization Single cell encapsulation via pickering emulsion for bio-pesticides application
CA3115355A1 (en) 2018-10-16 2020-04-23 Silicycle Inc. Tunable process for silica capsules/spheres preparation and their use
CA3116889A1 (en) 2018-10-18 2020-04-23 Topikos Pharmaceuticals, Inc. Organosilanes for the treatment of infections
CN109793012B (zh) * 2019-01-18 2021-03-02 美丽国土（北京）生态环境工程技术研究院有限公司 天然抑藻剂及其制备方法和应用
JP7395612B2 (ja) * 2019-04-17 2023-12-11 ザ プロクター アンド ギャンブル カンパニー カプセル
WO2020214878A1 (en) 2019-04-17 2020-10-22 The Procter & Gamble Company Methods of making capsules
MX2021012434A (es) * 2019-04-17 2022-01-19 Procter & Gamble Capsulas.
CN110237786B (zh) * 2019-06-19 2021-05-18 中南林业科技大学 一种释放可控的抑菌精油微胶囊的制备方法
CN114080212B (zh) * 2019-07-09 2024-12-27 株式会社Lg生活健康 化妆品用胶囊
AU2020365197A1 (en) 2019-10-18 2022-06-02 Topikos Scientific, Inc. Antimicrobial organosilanes
CO2019012045A1 (es) * 2019-10-29 2021-04-30 Biologicos Estrategicos Bioest S A S Formulación agroquímica antifúngica verde basada en nanomateriales de silicio y zinc
AU2021274996B2 (en) 2020-05-22 2026-04-09 Sol-Gel Technologies Ltd. Stabilized microcapsules, method of their preparation and uses thereof
KR102477180B1 (ko) * 2020-06-04 2022-12-14 서울대학교산학협력단 색전 물질
US12077728B2 (en) 2020-10-16 2024-09-03 The Procter & Gamble Company Laundry care additive particles
HUE069038T2 (hu) 2020-10-16 2025-02-28 Procter & Gamble Mag/héj szerkezetû kapszulát tartalmazó vízoldékony egyedi csomagolású árucikk
JP7544969B2 (ja) 2020-10-16 2024-09-03 ザ プロクター アンド ギャンブル カンパニー カプセルを含む液体布地ケア組成物
US11938349B2 (en) 2020-10-16 2024-03-26 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising capsules
US12458942B2 (en) 2020-10-16 2025-11-04 The Procter & Gamble Company Capsules
CN118451170A (zh) * 2021-12-23 2024-08-06 花王株式会社 清洁剂组合物
US12497579B2 (en) 2022-04-12 2025-12-16 The Procter & Gamble Company Fabric care unit dose articles with capsules
NL2034584B1 (en) * 2023-04-14 2024-10-21 Iamfluidics Holding B V Method for preservation of an active compound, formulation and preservative
CN118044507B (zh) * 2024-04-16 2024-08-16 淮南市农业技术推广中心 一种载药体系及其制备方法与应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61254243A (ja) * 1985-05-08 1986-11-12 Lion Corp マイクロカプセルの製造方法
AT389465B (de) 1987-08-18 1989-12-11 Kwizda Fa F Johann Verfahren zur bildung von mikrokapseln oder mikromatrixkoerpern
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
EP0551796B1 (en) 1992-01-03 1997-08-13 Novartis AG Microcapsule suspension and a process for its preparation
JPH0647273A (ja) * 1992-07-27 1994-02-22 Suzuki Yushi Kogyo Kk 着色球状微粒子及びその製造方法
ES2216360T3 (es) 1998-02-06 2004-10-16 Seiwa Kasei Co., Ltd. Microcapsula con pared particular y su procedimiento de fabricacion.
DE19810803A1 (de) 1998-03-12 1999-09-16 Wacker Chemie Gmbh Verfahren zur Herstellung mikroverkapselter Produkte mit Organopolysiloxanwänden
DE1104287T1 (de) 1998-08-13 2001-12-20 Sol-Gel Technologies Ltd., Tel Aviv Verfahren zur herstellung von mit funktionalisierten molekülen beladene oxid-mikrokapseln und die daraus erhaltenen produkte
DE19842766A1 (de) 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
AU4775400A (en) 1999-05-25 2000-12-12 Sol-Gel Technologies Ltd. A method for obtaining photostable sunscreen compositions
ES2366886T1 (es) 2000-04-21 2011-10-26 Sol-Gel Technologies Ltd. Composición que presenta estabilidad de formulación potenciada y administración de ingredientes activos tópicos potenciado.
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US20050156340A1 (en) 2004-01-20 2005-07-21 E Ink Corporation Preparation of capsules
GB2377078B (en) 2001-06-27 2003-06-04 Morgan Crucible Co Fuel cell or electrolyser construction
DE10139171A1 (de) 2001-08-16 2003-02-27 Basf Ag Verwendung von Mikrokapseln in Gipskartonplatten
IL161782A0 (en) 2001-11-08 2005-11-20 Sol Gel Technologies Ltd Compositions containing oils havinga specific gravity higher than the specific gravity of water
GB0202853D0 (en) 2002-02-07 2002-03-27 Dow Corning Encapsulation process and encapsulated compositions
DE10214257A1 (de) 2002-03-28 2003-10-16 Merck Patent Gmbh Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden
US6958848B2 (en) 2002-05-23 2005-10-25 E Ink Corporation Capsules, materials for use therein and electrophoretic media and displays containing such capsules
WO2004022081A1 (de) 2002-09-07 2004-03-18 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einem gehalt an anti-freezing proteinen und/oder anti-freezing glycoproteinen
US7470840B2 (en) 2003-01-08 2008-12-30 University Of Massachusetts Liquid-liquid interfacial nanoparticle assemblies
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
DE10318044A1 (de) 2003-04-17 2004-11-04 Basf Ag Verwendung von wässrigen Mikrokapseldispersionen als Wärmeträgerflüssigkeiten
KR100524820B1 (ko) 2003-06-17 2005-10-31 한국화학연구원 실리카 마이크로캡슐의 제조방법
JP2007500590A (ja) * 2003-07-31 2007-01-18 ゾル−ゲル テクノロジーズ エルティーディー． 活性成分が充填されたマイクロカプセル及びその製造方法
GB2416524A (en) 2004-07-24 2006-02-01 Dow Corning Microcapsules with siloxane walls formed in situ
US20060269441A1 (en) 2005-05-25 2006-11-30 Ochomogo Maria G Nanosilica-based food contact sanitizer
DE102005033002A1 (de) 2005-07-14 2007-01-18 Basf Ag Wässrige Monomeremulsionen enthaltend Hydrophobin
EA015815B1 (ru) * 2005-08-02 2011-12-30 Сол-Джел Текнолоджиз Лтд. Покрытие из оксида металла для водонерастворимых ингредиентов
CA2622990C (en) 2005-09-23 2014-06-10 Basf Se Novel agrochemical formulations
US10925279B2 (en) 2006-09-06 2021-02-23 Syngenta Participations Ag Pickering emulsion formulations
WO2008072239A2 (en) 2006-12-12 2008-06-19 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
JP5259621B2 (ja) 2006-12-28 2013-08-07 ダウ・コーニング・コーポレイション 多核マイクロカプセル
US20100047357A1 (en) 2007-02-01 2010-02-25 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
US9870123B1 (en) 2008-04-18 2018-01-16 Universal Electronics Inc. Selecting a picture of a device to identify an associated codeset
JP2011529392A (ja) 2008-07-31 2011-12-08 ゾル−ゲル テクノロジー リミテッド 活性成分および金属酸化物シェルを含むマイクロカプセル、その製造方法およびその使用
BR112012012023A2 (pt) 2009-12-31 2016-05-17 Sol Gel Technologies Ltd processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
ES2902498T3 (es) 2011-06-29 2022-03-28 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta

Also Published As

Publication number Publication date
CA2980792C (en) 2020-04-28
US20200114327A1 (en) 2020-04-16
CA2732368C (en) 2017-11-14
KR20110084151A (ko) 2011-07-21
CN102112219A (zh) 2011-06-29
AU2009277962A1 (en) 2010-02-04
ZA201101504B (en) 2011-11-30
MX2011000682A (es) 2011-03-25
WO2010013250A3 (en) 2010-07-15
JP2011529392A (ja) 2011-12-08
WO2010013250A2 (en) 2010-02-04
EP2307129A2 (en) 2011-04-13
IL210430A0 (en) 2011-03-31
US20110177951A1 (en) 2011-07-21
EA201170271A1 (ru) 2011-10-31
CA2980792A1 (en) 2010-02-04
US10688462B2 (en) 2020-06-23
CA2732368A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
BRPI0916820A2 (pt) processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas
BRPI0812521A2 (pt) Composto, composição farmacêutica, método para o tratamento de doença em um mamífero, processo para a preparação de um composto, e, uso de um composto
BRPI0812851A2 (pt) Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BRPI0918972A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso
BRPI0919488A2 (pt) composto, uso de um composto, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto
BRPI0921687A2 (pt) Composto , conjugado , uso de um composto , composição farmacêutica, processo para preparar uma composição famacêutica , método para tratar um mamífero em necessidade do mesmo ,e, método para tratar ou prevenir um tumor em um mamífero.
BRPI0820578A2 (pt) Vírus da varíola, processo para preparar um vírus da varíola, composição, uso de um vírus da varíola ou de uma composição, e, método para tratar doenças
BRPI0920180A2 (pt) Composto, uso de um composto, método para tratar uma infecção bacteriana em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto
BRPI0906805A2 (pt) Composto, processo para preparar o enanciômero puro, composição farmacêutica, uso do enanciômero puro, métodos para prevenir ou tratar doença em um animal de sangue quente, e, combinação
BRPI1009022A2 (pt) "composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
BRPI0906786A2 (pt) Composto, processo para a preparação de um composto, uso de um composto, método para o tratamento de uma doença ou condição, composição farmacêutica, processo para a preparação de uma composição farmacêutica, produto, e, kit.
FI20085543L (fi) Irrokemateriaalikoostumus, pohjamateriaali ja menetelmä pohjamateriaalin valmistamiseksi, pintakäsittelyaine pohjamateriaalia varten sekä pintakäsittelyaineen käyttö
BR112012026843A2 (pt) composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv
BRPI0924622A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso.
BRPI0820576A2 (pt) "vírus da varíola, processo para preparar o mesmo, composição, uso de um vírus da varíola uo uma composição, e método para tratar doenças"
BRPI0919876A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para intensificar a qualidade do sono, para tratar insônia, e para tratar ou controlar obesidade em um paciente mamífero que necessita do mesmo.
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
BRPI0915101A2 (pt) composto, uso do mesmo, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto
BRPI0921399A2 (pt) composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante
BRPI0811275A2 (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BRPI0917442A2 (pt) composições compreendendo tensoativo e microcápsulas, processo para o tratamento de superfícies, e, método para preparar composições
BRPI0822946A2 (pt) Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BR112012031487A2 (pt) processo para a produção de uma emulsão em água, emulsão de óleo em água, composição imunogênica, uso de uma emulsão de óleo em água ou da composição imunogênica,método de tratamento,e,kit
BRPI0915856A2 (pt) processo para preparar micropartículas, uso de um auxiliar de processamento, micropartículas, e, composição
BRPI0911709A2 (pt) composto, processo para a produção de um composto, composição farmacêutica e método de tratar uma doença mediada a ciclofilina em um mamífero

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE US 61/085,255 DE 31/07/2008, REIVINDICADA PELO PCT/IL2009/000751, POR PERDA DE PRAZO PARA PEDIDO ENTRADA DO PCT NO RO/IL. TAL ENTRADA DEVERIA TER SIDO REALIZADA ATE O DIA 31/07/2009, FINAL DO PRAZO DE 12 MESES, E FOI REALIZADA NO DIA 02/08/2009, HAVENDO APENAS A JUSTIFICATIVA DE FECHAMENTO DO RO/IL NO DIA 01/08/2009, APONTADA NO IB/301.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2375 DE 12-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.